Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
| Price | $12.10 |
|---|---|
| Market cap | $38.31M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
| 52-week range | 6.75-130.37 |
| Beta | 0.55 |
Explore AFJK's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.